Innovations in immunotherapies and personalized medicine, along with increased healthcare investments, are reshaping cancer ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

A French pharmaceutical giant is acquiring a biotech and its rare immunology disease treatment which is already approved in ...

Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.

Bristol Myers Squibb leapt into the drug industry’s most intense new rivalry on Monday, signing a deal to potentially spend ...

An outbreak of Salmonella infections traced to cucumbers from Florida is growing. As of May 30, 45 people across 18 states had been infected. Sixteen ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

Using flawed studies and scientific journal publications, abortion opponents are building a body of research meant to ...

PharmAla says its LaNeo MDMA drug products are exclusively available through a qualified practitioner’s prescription and ...